![](/img/cover-not-exists.png)
Fewer bone disease events, improvement in bone remodeling, and evidence of bone healing with bortezomib plus melphalan–prednisone vs. melphalan–prednisone in the phase III VISTA trial in multiple myeloma
Michel Delforge, Evangelos Terpos, Paul G. Richardson, Ofer Shpilberg, Nuriet K. Khuageva, Rudolf Schlag, Meletios A. Dimopoulos, Martin Kropff, Ivan Spicka, Maria T. Petrucci, Olga S. Samoilova, MariVolume:
86
Year:
2011
Language:
english
Pages:
13
DOI:
10.1111/j.1600-0609.2011.01599.x
File:
PDF, 364 KB
english, 2011